Efforia
Matthew Amsden is an experienced entrepreneur and executive currently serving as Co-Founder and CEO of Efforia, with a product launch planned for the third quarter of 2024. Previously, Amsden founded and led ProofPilot, a suite of online tools designed to facilitate randomized controlled trials, from January 2012 to July 2022. Amsden also held the role of Director at Cyclogram, focusing on strategy and software development for research projects involving randomized trials from November 2005 to December 2011. Earlier career experience includes a position as Senior Business Analyst at Abt Associates, a Client Program Manager at Be Free, as well as roles at MBNA America and Bangor International Airport. Amsden holds two MBA degrees in Marketing from the University of Maine and McGill University, along with a BS in Marketing and International Business from the University of Maine.
This person is not in any teams
Efforia
Efforia enables health and wellness brands to generate the clinical evidence that all consumers increasingly seek. We are democratizing the clinical trial. With Efforia, brands can generate protocols to prove their product is effective; participants can find products and services to discover what actually works for them; and everyone can create evidence they can use and trust quickly, affordably, and effectively.